![Dmitry Popov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dmitry Popov
Gründer bei Maxwell Asset Management LLC (Private Equity)
Aktive Positionen von Dmitry Popov
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Maxwell Asset Management LLC (Private Equity)
![]() Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | Gründer | 01.01.2008 | - |
Private Equity Investor | 01.01.2008 | - | |
MYR GmbH
![]() MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Dmitry Popov
Statistik
International
Russland | 2 |
Deutschland | 2 |
Operativ
Founder | 1 |
Private Equity Investor | 1 |
Chief Executive Officer | 1 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Maxwell Asset Management LLC (Private Equity)
![]() Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | Finance |
MYR GmbH
![]() MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | Health Technology |
- Börse
- Insiders
- Dmitry Popov
- Erfahrung